Bombay Dyeing & Manufacturing Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 29, 2025, 9:23 pm

Quick Insight

Bombay Dyeing & Manufacturing Company Ltd's current market cap of ₹3,506 Cr. seems notably high given its P/E ratio of 119, reflecting a potential overvaluation. The company's ROE and ROCE at 1.37% and 2.60% respectively are quite low, indicating inefficiency in capital utilization. With an OPM of -4%, profitability remains a concern, despite a net profit of ₹490 Cr. The high level of borrowings at ₹3 Cr. could pose risks, especially with an ICR of 0.18x. Shareholder distribution shows a significant stake held by promoters at 53.59%, with limited institutional ownership. Investors should approach with caution due to these concerning financial metrics and high valuation multiples.

Competitors of Bombay Dyeing & Manufacturing Company Ltd

All Competitor Stocks of Bombay Dyeing & Manufacturing Company Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:40 pm

Below is a detailed analysis of the quarterly data for Bombay Dyeing & Manufacturing Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 378.00 Cr.. The value appears strong and on an upward trend. It has increased from 359.00 Cr. (Mar 2025) to 378.00 Cr., marking an increase of 19.00 Cr..
• For Expenses, as of Jun 2025, the value is 392.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 372.00 Cr. (Mar 2025) to 392.00 Cr., marking an increase of 20.00 Cr..
• For Operating Profit, as of Jun 2025, the value is -14.00 Cr.. The value appears to be declining and may need further review. It has decreased from -13.00 Cr. (Mar 2025) to -14.00 Cr., marking a decrease of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is -4.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded -4.00%.
• For Other Income, as of Jun 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 37.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is -24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 9.00% (Mar 2025) to -24.00%, marking a decrease of 33.00%.
• For Net Profit, as of Jun 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.67. The value appears strong and on an upward trend. It has increased from 0.56 (Mar 2025) to 0.67, marking an increase of 0.11.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:30 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:45 pm

Below is a detailed analysis of the balance sheet data for Bombay Dyeing & Manufacturing Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 41.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 41.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,302.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,805.00 Cr. (Mar 2024) to 2,302.00 Cr., marking an increase of 497.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 647.00 Cr.. The value appears to be improving (decreasing). It has decreased from 709.00 Cr. (Mar 2024) to 647.00 Cr., marking a decrease of 62.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,993.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,558.00 Cr. (Mar 2024) to 2,993.00 Cr., marking an increase of 435.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 583.00 Cr.. The value appears strong and on an upward trend. It has increased from 575.00 Cr. (Mar 2024) to 583.00 Cr., marking an increase of 8.00 Cr..
• For CWIP, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 27.00 Cr., marking an increase of 13.00 Cr..
• For Investments, as of Mar 2025, the value is 1,466.00 Cr.. The value appears strong and on an upward trend. It has increased from 746.00 Cr. (Mar 2024) to 1,466.00 Cr., marking an increase of 720.00 Cr..
• For Other Assets, as of Mar 2025, the value is 918.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,224.00 Cr. (Mar 2024) to 918.00 Cr., marking a decrease of 306.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,993.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,558.00 Cr. (Mar 2024) to 2,993.00 Cr., marking an increase of 435.00 Cr..

Notably, the Reserves (2,302.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Bombay Dyeing & Manufacturing Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 142.77. This value is within the healthy range. It has increased from -25.02 (Mar 23) to 142.77, marking an increase of 167.79.
• For Diluted EPS (Rs.), as of Mar 24, the value is 142.77. This value is within the healthy range. It has increased from -25.02 (Mar 23) to 142.77, marking an increase of 167.79.
• For Cash EPS (Rs.), as of Mar 24, the value is 144.26. This value is within the healthy range. It has increased from -23.41 (Mar 23) to 144.26, marking an increase of 167.67.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 89.42. It has increased from -61.64 (Mar 23) to 89.42, marking an increase of 151.06.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 89.42. It has increased from -61.64 (Mar 23) to 89.42, marking an increase of 151.06.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 81.75. It has decreased from 129.45 (Mar 23) to 81.75, marking a decrease of 47.70.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 2.99. This value is within the healthy range. It has decreased from 3.28 (Mar 23) to 2.99, marking a decrease of 0.29.
• For PBIT / Share (Rs.), as of Mar 24, the value is 1.47. This value is within the healthy range. It has decreased from 1.67 (Mar 23) to 1.47, marking a decrease of 0.20.
• For PBT / Share (Rs.), as of Mar 24, the value is 176.71. This value is within the healthy range. It has increased from -23.65 (Mar 23) to 176.71, marking an increase of 200.36.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 142.75. This value is within the healthy range. It has increased from -25.02 (Mar 23) to 142.75, marking an increase of 167.77.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 142.76. This value is within the healthy range. It has increased from -25.02 (Mar 23) to 142.76, marking an increase of 167.78.
• For PBDIT Margin (%), as of Mar 24, the value is 3.65. This value is below the healthy minimum of 10. It has increased from 2.53 (Mar 23) to 3.65, marking an increase of 1.12.
• For PBIT Margin (%), as of Mar 24, the value is 1.79. This value is below the healthy minimum of 10. It has increased from 1.28 (Mar 23) to 1.79, marking an increase of 0.51.
• For PBT Margin (%), as of Mar 24, the value is 216.16. This value is within the healthy range. It has increased from -18.27 (Mar 23) to 216.16, marking an increase of 234.43.
• For Net Profit Margin (%), as of Mar 24, the value is 174.62. This value exceeds the healthy maximum of 10. It has increased from -19.33 (Mar 23) to 174.62, marking an increase of 193.95.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 174.63. This value exceeds the healthy maximum of 20. It has increased from -19.32 (Mar 23) to 174.63, marking an increase of 193.95.
• For Return on Networth / Equity (%), as of Mar 24, the value is 157.39. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 157.39, marking an increase of 157.39.
• For Return on Capital Employeed (%), as of Mar 24, the value is 1.50. This value is below the healthy minimum of 10. It has decreased from 2.39 (Mar 23) to 1.50, marking a decrease of 0.89.
• For Return On Assets (%), as of Mar 24, the value is 115.15. This value is within the healthy range. It has increased from -17.25 (Mar 23) to 115.15, marking an increase of 132.40.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -2.16 (Mar 23) to 0.00, marking an increase of 2.16.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. It has increased from -2.92 (Mar 23) to 0.00, marking an increase of 2.92.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.60. It has decreased from 0.74 (Mar 23) to 0.60, marking a decrease of 0.14.
• For Current Ratio (X), as of Mar 24, the value is 2.04. This value is within the healthy range. It has increased from 1.03 (Mar 23) to 2.04, marking an increase of 1.01.
• For Quick Ratio (X), as of Mar 24, the value is 1.58. This value is within the healthy range. It has increased from 0.32 (Mar 23) to 1.58, marking an increase of 1.26.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.72. This value is below the healthy minimum of 4. It has increased from 0.88 (Mar 23) to 1.72, marking an increase of 0.84.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 0.18. This value is below the healthy minimum of 3. It has increased from 0.12 (Mar 23) to 0.18, marking an increase of 0.06.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -2.06. This value is below the healthy minimum of 3. It has decreased from 0.01 (Mar 23) to -2.06, marking a decrease of 2.07.
• For Enterprise Value (Cr.), as of Mar 24, the value is 2,785.25. It has decreased from 4,603.18 (Mar 23) to 2,785.25, marking a decrease of 1,817.93.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.65. This value is within the healthy range. It has decreased from 1.72 (Mar 23) to 1.65, marking a decrease of 0.07.
• For EV / EBITDA (X), as of Mar 24, the value is 45.13. This value exceeds the healthy maximum of 15. It has decreased from 67.98 (Mar 23) to 45.13, marking a decrease of 22.85.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.95. This value is within the healthy range. It has increased from 0.43 (Mar 23) to 1.95, marking an increase of 1.52.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 23) which recorded 0.00.
• For Price / BV (X), as of Mar 24, the value is 1.76. This value is within the healthy range. It has increased from -0.94 (Mar 23) to 1.76, marking an increase of 2.70.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.95. This value is within the healthy range. It has increased from 0.43 (Mar 23) to 1.95, marking an increase of 1.52.
• For EarningsYield, as of Mar 24, the value is 0.89. This value is below the healthy minimum of 5. It has increased from -0.44 (Mar 23) to 0.89, marking an increase of 1.33.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness